pentobarbital will minimize the level or result of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Use of other treatment plans is strongly encouraged when linagliptin is to be administered using a CYP3A4 inducerpentobarbital will decrease the level or outcome of docetaxel by affecting hepatic/intestinal enz